Fate Therapeutics logo
Fate Therapeutics FATE
$ 2.08 -6.53%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Fate Therapeutics Interest Expense 2011-2024 | FATE

Annual Interest Expense Fate Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
29.6 M 26.7 M 4.84 M -45.3 M 1.75 M 1.7 M 1.27 M 1.64 M 2.22 M 549 K 796 K 487 K 127 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
29.6 M -45.3 M 2.02 M

Quarterly Interest Expense Fate Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
4.7 M 6.66 M - 6.11 M 9.81 M 9.71 M - 2.83 M 7 M 8.78 M - 11.3 M -8.35 M 1.12 M - -27.2 M 635 K 972 K - 400 K 409 K 405 K - 429 K 425 K 412 K - 378 K 212 K 266 K - 385 K 435 K 488 K - 562 K 563 K 558 K - 187 K 28 K 43 K - 230 K 88 K 100 K - -463 K - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
11.3 M -27.2 M 1.13 M